Advertisement
Home »

Potential synergy between radiotherapy and CAR T-cells – A multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy.

Feb 27, 2023

ABOUT THE CONTRIBUTORS

  • Jiaqi Fan

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Anne Adams

    Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Noëlle Sieg

    Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.

    Jan-Michel Heger

    Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.

    Philipp Gödel

    Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.

    Nadine Kutsch

    Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.

    David Kaul

    Department for Radiation Oncology, Charité School of Medicine and University Hospital Berlin, Berlin, Germany.

    Marcel Teichert

    Department of Hematology and Oncology, University Hospital Essen, Essen, Germany.

    Bastian von Tresckow

    Department of Hematology and Oncology, University Hospital Essen, Essen, Germany.

    Veit Bücklein

    Department of Hematology and Oncology, University Hospital Munich (LMU Munich), Munich, Germany.

    Gretha Goesmann

    Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

    Minglun Li

    Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

    Nathalie Struve

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Maike Trommer

    Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

    Philipp Linde

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Johannes Rosenbrock

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Eren Celik

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Olaf Penack

    Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Augustenburger Platz 1, 13353 Berlin, Germany.

    Martin Stuschke

    Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany.

    Marion Subklewe

    Department of Hematology and Oncology, University Hospital Munich (LMU Munich), Munich, Germany.

    Claus Belka

    Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

    Michael von Bergwelt-Baildon

    Department of Hematology and Oncology, University Hospital Munich (LMU Munich), Munich, Germany.

    Peter Borchmann

    Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.

    Simone Marnitz

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

    Christian Baues

    Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany. Electronic address: christian.baues@uk-koeln.de.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement